Skip to content
OpenCapital
Get started

NeoGenomics NEO Reportable Segment — Depreciation

Similar metrics at other companies

Concentrix Corporation logo
CNXCReportable Segment — Depreciation
$55.91M+1.5%
Praxis Precision Medicines, Inc. logo
PRAXReportable Segment — Depreciation expense
$39K-17.0%
Insmed logo
INSMReportable Segment — Depreciation
$2.93M+55.8%
GXO Logistics logo
GXOReportable Segment — Depreciation expense
$86M+7.5%
SiTime Corporation logo
SITMReportable Segment — Depreciation
$4.34M+35.7%
Tarsus Pharmaceuticals, Inc. logo
TARSReportable Segment — Depreciation and amortization expense
-$437K+5.0%

Other financials

Income statement

See full
Revenue$186.7M+11.1%
Gross profit$80.9M+10.4%
Operating income-$18.2M+34.4%
Net income-$17.1M+34.0%
EPS (diluted)-$0.13+35.0%

Balance sheet

See full
Cash & equivalents$146.1M-57.8%
Total debt$66.3M+5.3%
Total equity$828.8M-6.7%
Total assets$1.3B-15.9%

Cash flow

See full
Operating cash flow-$8.1M+67.9%
CapEx$5.0M+11.1%
Free cash flow-$13.1M+56.0%

Valuation

See full
Market cap$1.68B+86.5%
Enterprise value$1.6B+159%
P/S2.3×+0.9×

Profitability

See full
Gross margin43.2%-1.1pp
Operating margin-14.2%+1.1pp
Net margin-13.3%+2.4pp
FCF margin-4.9%—

Returns & leverage

See full
Return on equity-11.6%+6.2pp
Debt / equity0.1×0.0×
Current ratio4.4×+2.4×

Where this comes from

Reported directly by NeoGenomics in its filing.

Tagged under the XBRL concept us-gaap:Depreciation.

The official record: NeoGenomics’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about NeoGenomics's reportable segment — depreciation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is NeoGenomics's reportable segment — depreciation?
NeoGenomics (NEO) reported reportable segment — depreciation of $8.78M in Q1 2026.
How has NeoGenomics's reportable segment — depreciation changed year-over-year?
NeoGenomics's reportable segment — depreciation decreased by 6.3% year-over-year, from $9.37M to $8.78M.
What is the long-term trend for NeoGenomics's reportable segment — depreciation?
Over 3 years (2022 to 2025), NeoGenomics's reportable segment — depreciation has grown at a 0.7% compound annual growth rate (CAGR), from $35.37M to $36.07M.
What does reportable segment — depreciation mean?
The non-cash expense representing the wear and tear of tangible assets, such as laboratory equipment and facilities, utilized by the segment. It reflects the capital intensity required to maintain the segment's operational infrastructure.